Recital 11, Regulation (EU) 2026/491

In forcesince 4 Mar 2026

In addition, Annex XVIII to Implementing Regulation (EU) 2021/404 sets out the list of third countries or territories, or zones thereof, authorised for the entry into the Union of consignments of dairy products required to undergo a specific risk-mitigating treatment against foot and mouth disease. That list should be consistent with the list of third countries or parts thereof authorised for the introduction into the Union of consignments of raw milk, dairy products, colostrum and colostrum-based products and indicating the type of heat treatment required for such commodities set out in Annex I to Commission Regulation (EU) No 605/2010 [Commission Regulation (EU) No 605/2010 of 2 July 2010 laying down animal and public health and veterinary certification conditions for the introduction into the European Union of raw milk, dairy products, colostrum and colostrum-based products intended for human consumption (OJ L 175, 10.7.2010, p. 1, ELI: http://data.europa.eu/eli/reg/2010/605/oj).], as Regulation (EU) No 605/2010 was repealed and replaced by Implementing Regulation (EU) 2021/404. In that respect, the Emirates of Abu Dhabi and Dubai were listed in Annex I to Regulation (EU) No 605/2010 as parts of the United Arab Emirates authorised for the introduction into the Union of consignments of dairy products of camelid animals required to undergo a specific risk-mitigating treatment. However, due to an error, the Emirate of Abu Dhabi was omitted from the entry for the United Arab Emirates in the list set out in Annex XVIII to Implementing Regulation (EU) 2021/404 and therefore that Annex should be corrected to rectify that omission. Annex XVIII to Implementing Regulation (EU) 2021/404 should, therefore, be corrected accordingly.